Rocket Pharmaceuticals Inc (NAS:RCKT)
$ 17.19 0.37 (2.2%) Market Cap: 1.56 Bil Enterprise Value: 1.28 Bil PE Ratio: 0 PB Ratio: 4.06 GF Score: 36/100

Q2 2021 Rocket Pharmaceuticals Inc Earnings Call Transcript

Aug 09, 2021 / 08:30PM GMT
Release Date Price: $33.63 (-3.20%)
Operator

Welcome to the Rocket Pharmaceuticals Inc. Investor Conference Call. My name is Vanessa, and I will be your operator for today's call. (Operator Instructions).

I will now turn the call over to your host, Mayur Kasetty, Director of Business Development and Operations.

Mayur Kasetty

Thank you, Vanessa. Good afternoon, everyone. This is Mayur Kasetty, Director of Business Development and Operations and Investor Relations Lead at Rocket Pharmaceuticals. Thank you for joining us.

The purpose of this call is to share and discuss key updates on our clinical programs. Before we begin, I would like to briefly discuss the use of forward-looking statements on this conference call. Statements we make on this call may include statements which are not historical facts and are considered forward-looking within the meaning of the securities laws and which are usually identified by the use of words such as anticipates, believes, estimates, expects, intends, may, plans, projects, seeks, should, will and variations of such words or similar expressions. We intend these

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot